Phair, 2020, (zilver ptx) ¿ primary patency of long-segment femoropopliteal artery lesions in patients with peripheral arterial occlusive disease treated with paclitaxel-eluting technology.In this retrospective cohort study, a single-center, prospectively maintained database was interrogated to find all consecutive patients undergoing endovascular intervention with paclitaxel-coated balloons and paclitaxel-eluting stents from 2015 to 2018 for long segment (100 mm) femoropopliteal disease.Patients were followed after their index procedure for target lesion restenosis, defined as a reduction in lumen diameter by greater than 50% as measured by duplex ultrasonography.This file is capturing 5 cases of occlusion.Patient outcome: -occlusions were typically treated with stents.
|
Pma/510(k) # p100022/s027.Device evaluation the zisv6 device of unknown lot number involved in this complaint was implanted in the patient and was not available for evaluation.With the information provided, a document-based investigation was conducted.Lab evaluation n/a document review as the rpn and lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution all zisv6 devices are subject to visual a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.It should be noted that occlusion is listed as a known potential adverse event within the instructions for use (ifu118-6).There is no evidence to suggest the user did not follow the ifu.Image review n/a root cause review a definitive root cause could not be determined from the available information.A possible root cause could be attributed to patient re existing/underlying conditions.From the literature article it is known that patient pre-existing conditions included hypertension, hyperlipidemia, diabetes, smoking, coronary artery disease (cad), history of ischemic stroke or transient ischemic attack, history of vascular surgery, history of lower limb amputation and rutherford classifications between 3 and 6.Occlusion is also listed as a known potential adverse event within the ifu and is a common adverse event of endovascular procedures that can be caused by obstruction to the vessel (e.G.During percutaneous transluminal angioplasty (pta) and/or stenting).Summary the complaint is confirmed based on customer testimony.The patient outcome is unknown.Complaints of this nature will continue to be monitored for potential emerging trends.
|